Videos

Mary S. McCabe, RN, MA, discusses an evaluation of nurse practitioner-led survivorship care.

Joel Stettler, BSN, RN, OCN, Moffitt Cancer Center, discusses common causes for falls in the inpatient malignant hematology population, and what can be done to reduce these incidents.

Ryan Nipp, MD, discusses a study of symptom burden and hospital length of stay in patients with incurable cancer.

Melisa Wong, MD, discusses an analysis of age and comorbidity on treatment of non-small cell lung cancer recurrence. Wong presented this analysis at the 2016 ASCO Annual Meeting.

Donna Clark, RN, Mitchell Cancer Institute, discusses the difference that a caring oncology nurse can make for patients.

Kyung Chu, RN, NYU Langone Perlmutter Cancer Center, discusses treating patients with different subtypes of KRAS mutation.

Jeannine Brant, PhD, APRN-CNS, AOCN, of the Billings Clinic in Montana, discusses the importance of assessing and managing breakthrough cancer pain.

Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, discusses the role of oncology nurses in handling sleep disturbances.

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.

Inna Tsuker, PharmD, BCPS, Cancer Treatment Centers of America, discusses a team-based approach implemented to prevent patients with cancer from falling.

Darcy Burbage, RN, MSN, AOCN, CBCN, Helen F. Graham Cancer Center & Research Institute, discusses risk factors that oncology nurses should be aware of when thinking about chemotherapy-induced peripheral neuropathy (CIPN).

​Joan Lockhart, PhD, RN, CORLN, AOCN, CNE, ANEF, FAAN, clinical professor at Duquesne University School of Nursing, discusses issues oncology nurses should monitor for when treating patients with head and neck cancer.

Paloma Pearson, manager of clinical operations, Baylor Scott and White Hillcrest Medical Center, talks about how technology is changing the landscape of healthcare.

Caitlin Braithwaite, BAN, RN, OCN, University of Iowa Hospitals and Clinics, discusses her use of hand massage in patients with cancer, and what her fellow nurses thought of the implementation.

Meredith Buxton, PhD, University of California San Francisco, discusses the I-SPY 2 trial, for which she is the executive director.

Norman E. Sharpless, MD, Professor of Medicine & Genetics Chair, The Lineberger Comprehensive Cancer Center, discusses a recent study that evaluated sunscreen’s effectiveness in reducing melanoma risk.

Barry Berger, MD, Exact Sciences Corporation, discusses Cologuard, an at-home screening for colorectal cancer.

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses nurses’ roles in treating patients receiving immunotherapy, especially combination checkpoint blockades, which are typically associated with higher risks of adverse events.

Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.

Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses some of the adverse effects of newly approved targeted therapies.

Jae Park, MD, Memorial Sloan Kettering Cancer Center, explains CAR T-cell therapy, which is currently being investigated in patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma.

Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the great strides in kidney cancer care that have been made in the past decade.

Oliver Sartor, MD, Medical Director Tulane Cancer Center, discusses when he administers Radium-223 in his practice.

Sarah B. Goldberg, MD, MPH, assistant professor of medicine at Yale Cancer Center, discusses new treatment options for patients with non-small cell lung cancer (NSCLC).

Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses misconceptions women have about being pregnant with a breast cancer diagnosis.

Kevin Hughes, MD, FACS, breast surgeon, Massachusetts General Hospital, discusses the impact of lumpectomies on elderly patients with breast cancer.

Rajni Kannan, BS, MS, RN, ANP-BC, from Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses the adverse events (AEs) commonly seen with combinations of therapies to treat melanoma.

Kimberly J. Van Zee, MS, MD, FACS, discusses difficult decisions women with a Ductal carcinoma in situ (DCIS) diagnosis face.